Press Releases

FUJIFILM Biotechnologies’ Lars Petersen Wins 2025 CPHI “CEO of the Year

FUJIFILM Biotechnologies’ CEO Lars Petersen Named “CEO of the Year” at CPHI Pharma Awards 2025 FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) specializing in biologics, vaccines, and advanced therapies, proudly announces that its President and Chief Executive…

Read MoreFUJIFILM Biotechnologies’ Lars Petersen Wins 2025 CPHI “CEO of the Year
Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Advancing Data Center AI Infrastructure” – emphasizes the strategic leap in Qualcomm’s architecture for enterprise-scale AI Qualcomm Technologies, Inc. has announced the launch of its next-generation AI inference-optimized solutions for data centers: the Qualcomm® AI200 and Qualcomm® AI250 chip-based accelerator…

Read MoreQualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference
Chemetall

IMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025

IMCD Showcases Greener, Smarter, and Patient-Centric Pharmaceutical Innovations at CPHI Frankfurt 2025 a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced its participation at CPHI Frankfurt 2025, taking place from 28–30 October. At this…

Read MoreIMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025

Arrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis

Arrowhead Pharmaceuticals Announces Completion of Global Licensing and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a leading biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics, announced today that its previously disclosed global licensing and collaboration agreement…

Read MoreArrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis